The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will be another remarkable year in this journey.
A lawyer for the employers predicts that discovery will show that collusion between drugmakers and PBMs had a significant impact on his clients' costs.
The only sustainable path to optimal metabolic health is one that tailors long-term lifestyle changes like diet, exercise, and sleep to each individual.
CVS, Cigna and UnitedHealth are firing back at the FTC in the wake of an administrative complaint the agency filed in September accusing their PBMs of artificially inflating insulin prices through a process it likened to "bribes."